Cargando…

A Novel Drug Delivery System: Hyodeoxycholic Acid-Modified Metformin Liposomes for Type 2 Diabetes Treatment

Metformin is a first-line drug for the clinical treatment of type 2 diabetes; however, it always leads to gastrointestinal tolerance, low bioavailability, short half-life, etc. Liposome acts as an excellent delivery system that could reduce drug side effects and promote bioavailability. Hyodeoxychol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Minghao, Gou, Tingting, Chen, Yuchen, Xu, Min, Chen, Rong, Zhou, Tao, Liu, Junjing, Peng, Cheng, Ye, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055618/ https://www.ncbi.nlm.nih.gov/pubmed/36985444 http://dx.doi.org/10.3390/molecules28062471

Ejemplares similares

Synthesis and Quantitative Structure-Property Relationships of Side Chain-Modified Hyodeoxycholic Acid Derivatives
por: Sabbatini, Paola, et al.
Publicado: (2013)

Fecal Hyodeoxycholic Acid Is Correlated With Tylosin-Induced Microbiome Changes in Growing Pigs
por: Trudeau, Michaela P., et al.
Publicado: (2018)

A “Trojan Horse” Strategy: The Preparation of Bile Acid-Modifying Irinotecan Hydrochloride Nanoliposomes for Liver-Targeted Anticancer Drug Delivery System Study
por: Zhou, Tao, et al.
Publicado: (2023)

Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases
por: Gou, Tingting, et al.
Publicado: (2023)

Synthesis of Five Known Brassinosteroid Analogs from Hyodeoxycholic Acid and Their Activities as Plant-Growth Regulators
por: Duran, María Isabel, et al.
Publicado: (2017)

Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists
por: De Marino, Simona, et al.
Publicado: (2017)

Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury in vitro
por: Li, Chang-Xiang, et al.
Publicado: (2019)

Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications
por: Cao, Yifeng, et al.
Publicado: (2022)

Synthesis of 2-Deoxybrassinosteroids Analogs with 24-nor, 22(S)-23-Dihydroxy-Type Side Chains from Hyodeoxycholic Acid
por: Carvajal, Rodrigo, et al.
Publicado: (2018)

Alginate Alleviates Dextran Sulfate Sodium-Induced Colitis by Promoting Bifidobacterium animalis and Intestinal Hyodeoxycholic Acid Synthesis in Mice
por: Pi, Yu, et al.
Publicado: (2022)

Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling
por: Zhong, Jing, et al.
Publicado: (2023)

Investigation of α,ω-Disubstituted Polyamine-Cholic Acid Conjugates Identifies Hyodeoxycholic and Chenodeoxycholic Scaffolds as Non-Toxic, Potent Antimicrobials
por: Sue, Kenneth, et al.
Publicado: (2023)

An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
por: Ma, Chongyang, et al.
Publicado: (2020)

Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
por: Chen, Zhongya, et al.
Publicado: (2012)

Adapting liposomes for oral drug delivery
por: He, Haisheng, et al.
Publicado: (2019)

Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
por: Yang, Jian, et al.
Publicado: (2016)

Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy
por: Wang, Wen-Yan, et al.
Publicado: (2019)

Liposomal Drug Delivery Systems and Anticancer Drugs
por: Olusanya, Temidayo O. B., et al.
Publicado: (2018)

Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
por: Shukla, Snehal K., et al.
Publicado: (2019)

Aromatized liposomes for sustained drug delivery
por: Li, Yang, et al.
Publicado: (2023)

In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting
por: Liu, Xueyan, et al.
Publicado: (2020)

Investigation of Fatty Acid Ketohydrazone Modified Liposome's Properties as a Drug Carrier
por: Hayashi, Keita, et al.
Publicado: (2015)

Liposomes for effective drug delivery to the ocular posterior chamber
por: Lai, Sisi, et al.
Publicado: (2019)

Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery
por: Gao, Dawei, et al.
Publicado: (2012)

Targeted Liposomal Drug Delivery to Monocytes and Macrophages
por: Kelly, Ciara, et al.
Publicado: (2011)

Recent Applications of Liposomes in Ophthalmic Drug Delivery
por: Mishra, Gyan P., et al.
Publicado: (2011)

Lysolipid containing liposomes for transendothelial drug delivery
por: Koklic, Tilen, et al.
Publicado: (2012)

Intravesical liposome drug delivery and IC/BPS
por: Janicki, Joseph J., et al.
Publicado: (2015)

Advances and Challenges of Liposome Assisted Drug Delivery
por: Sercombe, Lisa, et al.
Publicado: (2015)

Enhanced Drug Delivery to the Skin Using Liposomes
por: Blueschke, Gert, et al.
Publicado: (2018)

Liposomes with an Ethanol Fraction as an Application for Drug Delivery
por: Pilch, Ewa, et al.
Publicado: (2018)

Liposomes in Drug Delivery: How It All Happened
por: Gregoriadis, Gregory
Publicado: (2016)

Current developments in drug delivery with thermosensitive liposomes
por: Bi, Hongshu, et al.
Publicado: (2019)

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
por: Lu, Lu, et al.
Publicado: (2018)

Inulin-Modified Liposomes as a Novel Delivery System for Cinnamaldehyde
por: Xue, Minxing, et al.
Publicado: (2022)

Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes
por: Yuan, Zhi-xiang, et al.
Publicado: (2017)

Carboxymethyl Chitosan Modified Oxymatrine Liposomes for the Alleviation of Emphysema in Mice via Pulmonary Administration
por: Peng, Jianqing, et al.
Publicado: (2022)

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
por: Wei, Minyan, et al.
Publicado: (2015)

Preparing Size-Controlled Liposomes Modified with Polysaccharide Derivatives for pH-Responsive Drug Delivery Applications
por: Yanagihara, Shin, et al.
Publicado: (2023)

Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
por: Zhang, Wendian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f32dt2npqbdlmhb21t4q04hmfs